Cite
HARVARD Citation
Takebe, N. et al. (2019). A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction. British journal of clinical pharmacology. 85 (11), pp. 2499-2511. [Online].